GENESYS CAPITAL
Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology. Through its expertise and network, Genesys accelerates the development of commercially viable emerging companies that represent promising biotechnology investment opportunities.
GENESYS CAPITAL
Industry:
Biotechnology Health Care Life Science Venture Capital
Founded:
2000-01-01
Status:
Active
Contact:
(416) 598-3328
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt WordPress Font Awesome Nginx Microsoft Exchange Online Office 365 Mail
Similar Organizations
![]()
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
![]()
Roche Venture Fund
The Roche Venture Fund is the name given to the corporate venture fund of the healthcare company Roche.
Current Advisors List
Current Employees Featured

![]()
![]()
Founder
![]()
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-06-16 | Veralox Therapeutics | Genesys Capital investment in Series A - Veralox Therapeutics | 16.6 M USD |
| 2021-05-21 | Giiant Pharma | Genesys Capital investment in Seed Round - Giiant Pharma | 15 M CAD |
| 2021-02-02 | Flosonics | Genesys Capital investment in Venture Round - Flosonics | 14 M USD |
| 2020-09-08 | Inversago Pharma | Genesys Capital investment in Series B - Inversago Pharma | 35 M USD |
| 2020-01-29 | IDbyDNA | Genesys Capital investment in Series B - IDbyDNA | 20 M USD |
| 2019-11-19 | EBT Medical | Genesys Capital investment in Series A - EBT Medical | 10 M USD |
| 2019-04-02 | Fusion Pharmaceuticals | Genesys Capital investment in Series B - Fusion Pharmaceuticals | 105 M USD |
| 2018-07-25 | Inversago Pharma | Genesys Capital investment in Series A - Inversago Pharma | 7 M USD |
| 2018-01-29 | Flosonics | Genesys Capital investment in Seed Round - Flosonics | 5 M USD |
| 2018-01-11 | Adapsyn Bioscience | Genesys Capital investment in Venture Round - Adapsyn Bioscience | N/A |